The challenge of chemotherapy-related cognitive impairment: assessing and managing cognitive decline after cancer treatment
{{output}}
Chemotherapy-related cognitive impairment (CRCI) refers to a decline in cognitive function in patients during and after cancer treatment and is mainly associated with the use of cytotoxic chemotherapy (CT). As CT is still an essential component in the treatmen... ...